Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Exon Recombination02:32

Exon Recombination

3.1K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
3.1K
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

2.9K
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
2.9K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

5.7K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
5.7K
Mismatch Repair01:20

Mismatch Repair

5.4K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.4K
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

1.7K
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
1.7K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

14.8K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of novel regulators of LINE-1 expression via CRISPR/Cas9 screening.

Mobile DNA·2025
Same author

The Pan-RAF-MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS-MAPK Pathway with Activity across Diverse RAS- and RAF-Driven Cancers.

Cancer discovery·2024
Same author

Comparison of Robotic, Laparoscopic, and Open Resections of Nonmetastatic Colon Cancer.

Diseases of the colon and rectum·2023
Same author

Monitoring GAPDH activity and inhibition with cysteine-reactive chemical probes.

RSC chemical biology·2022
Same author

Selective Pharmaceutical Inhibition of PARP14 Mitigates Allergen-Induced IgE and Mucus Overproduction in a Mouse Model of Pulmonary Allergic Response.

ImmunoHorizons·2022
Same author

Reprogramming RNA processing: an emerging therapeutic landscape.

Trends in pharmacological sciences·2022

Related Experiment Video

Updated: Apr 25, 2026

A Method to Study de novo Formation of Chromatin Domains
07:34

A Method to Study de novo Formation of Chromatin Domains

Published on: August 23, 2019

5.0K

Reaction coupling between wild-type and disease-associated mutant EZH2.

Brooke M Swalm1, Sarah K Knutson, Natalie M Warholic

  • 1Epizyme, Inc. 400 Technology Square, Fourth Floor, Cambridge, Massachusetts 02139, United States.

ACS Chemical Biology
|August 26, 2014
PubMed
Summary

EZH2 and EZH1 enzymes methylate histone H3 lysine 27 (H3K27). Certain EZH2 mutations in non-Hodgkin lymphoma (NHL) can form the oncogenic H3K27me3 mark, sometimes with help from wild-type enzymes.

More Related Videos

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.9K
Author Spotlight: Enhanced Isolation of Interaction-Null Mutants in Yeast
02:44

Author Spotlight: Enhanced Isolation of Interaction-Null Mutants in Yeast

Published on: December 29, 2023

1.1K

Related Experiment Videos

Last Updated: Apr 25, 2026

A Method to Study de novo Formation of Chromatin Domains
07:34

A Method to Study de novo Formation of Chromatin Domains

Published on: August 23, 2019

5.0K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.9K
Author Spotlight: Enhanced Isolation of Interaction-Null Mutants in Yeast
02:44

Author Spotlight: Enhanced Isolation of Interaction-Null Mutants in Yeast

Published on: December 29, 2023

1.1K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • EZH2 and EZH1 are key protein methyltransferases catalyzing histone H3 lysine 27 (H3K27) methylation.
  • H3K27 trimethylation (H3K27me3) is a critical epigenetic mark associated with various cancers, notably non-Hodgkin lymphoma (NHL).
  • Specific heterozygous EZH2 point mutations (Tyr641, Ala677, Ala687) are frequently identified in NHL patients.

Purpose of the Study:

  • To investigate the catalytic mechanisms and substrate specificities of wild-type and mutant EZH2 enzymes.
  • To elucidate the role of enzyme-enzyme interactions in the formation of the oncogenic H3K27me3 mark in NHL.
  • To characterize the kinetic properties of PRC2 complexes containing wild-type and mutant EZH2.

Main Methods:

  • Enzyme kinetics assays to measure H3K27 methylation activity.
  • Analysis of substrate methylation states (unmethylated, mono-, di-, and tri-methylated H3K27).
  • Investigation of potential cooperative or coupling mechanisms between wild-type and mutant EZH2 forms.

Main Results:

  • Mutations at Tyr641 primarily enhance activity on H3K27me2, with limited activity on unmethylated H3K27.
  • Mutations at Ala677 and Ala687 demonstrate effective utilization of H3K27 substrates across all methylation states.
  • While some mutants require wild-type EZH2 for H3K27me3 formation, others can achieve this mark independently.
  • All PRC2 forms (wild-type and mutant) exhibit distributive catalysis kinetics.

Conclusions:

  • The catalytic behavior of EZH2 mutants in NHL is complex, with varying dependencies on wild-type enzyme for oncogenic H3K27me3.
  • Understanding these distinct enzymatic properties is crucial for developing targeted therapies for NHL.
  • The distributive catalytic mechanism is conserved across wild-type and mutant PRC2 complexes.